Loading...
The University of Chicago Header Logo
Keywords
Last Name
Institution

Connection

Search Results to Evan Stein

This is a "connection" page, showing the details of why an item matched the keywords from your search.

                     
                     

One or more keywords matched the following items that are connected to Stein, Evan

Item TypeName
Concept Hydroxymethylglutaryl CoA Reductases
Concept Oxidoreductases
Concept Hydroxymethylglutaryl-CoA Reductase Inhibitors
Concept Cholestenone 5 alpha-Reductase
Academic Article Efficacy and safety of lovastatin in adolescent males with heterozygous familial hypercholesterolemia: a randomized controlled trial.
Academic Article The lipid-lowering effects of atorvastatin, a new HMG-CoA reductase inhibitor: results of a randomized, double-masked study.
Academic Article Effects of high-dose simvastatin on adrenal and gonadal steroidogenesis in men with hypercholesterolemia.
Academic Article Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR* Trial).
Academic Article Effects of simvastatin, an HMG-CoA reductase inhibitor, in patients with hypertriglyceridemia.
Academic Article Efficacy and tolerability of adding prescription omega-3 fatty acids 4 g/d to simvastatin 40 mg/d in hypertriglyceridemic patients: an 8-week, randomized, double-blind, placebo-controlled study.
Academic Article Risk for myopathy with statin therapy in high-risk patients.
Academic Article Safety of rosuvastatin.
Academic Article Effect of alirocumab, a monoclonal proprotein convertase subtilisin/kexin 9 antibody, on lipoprotein(a) concentrations (a pooled analysis of 150 mg every two weeks dosing from phase 2 trials).
Academic Article Colesevelam hydrochloride: efficacy and safety in pediatric subjects with heterozygous familial hypercholesterolemia.
Academic Article Effects of simvastatin on C-reactive protein in mixed hyperlipidemic and hypertriglyceridemic patients.
Academic Article Low-density lipoprotein cholesterol reduction and prevention of cardiovascular disease.
Academic Article Effects of finasteride (MK-906), a 5 alpha-reductase inhibitor, on circulating androgens in male volunteers.
Academic Article Rosuvastatin improves the atherogenic and atheroprotective lipid profiles in patients with hypertriglyceridemia.
Academic Article Effect of lipid-lowering treatment on natural history of heterozygous familial hypercholesterolemia in past three decades.
Academic Article Long-term efficacy and safety of rosuvastatin 40 mg in patients with severe hypercholesterolemia.
Academic Article An investigative look: selective cholesterol absorption inhibitors--embarking on a new standard of care.
Academic Article Influence of age and gender on the plasma profiles of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitory activity following multiple doses of lovastatin and simvastatin.
Academic Article Effects of prescription omega-3-acid ethyl esters on non--high-density lipoprotein cholesterol when coadministered with escalating doses of atorvastatin.
Academic Article After ENHANCE: is more LDL cholesterol lowering even better?
Academic Article Effects of maximal doses of atorvastatin versus rosuvastatin on small dense low-density lipoprotein cholesterol levels.
Academic Article Comparison of the effects of high doses of rosuvastatin versus atorvastatin on the subpopulations of high-density lipoproteins.
Academic Article Statins and children: whom do we treat and when?
Academic Article Statin-associated muscle symptoms: impact on statin therapy-European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management.
Academic Article Comparison of the effects of maximal dose atorvastatin and rosuvastatin therapy on cholesterol synthesis and absorption markers.
Academic Article Comparison of statins in hypertriglyceridemia.
Academic Article Adverse effects of statin therapy: perception vs. the evidence - focus on glucose homeostasis, cognitive, renal and hepatic function, haemorrhagic stroke and cataract.
Academic Article Managing dyslipidemia in the high-risk patient.
Academic Article A systematic review and meta-analysis of statin therapy in children with familial hypercholesterolemia.
Academic Article Introduction: rosuvastatin--an efficacy assessment based on pooled trial data.
Academic Article Efficacy of rosuvastatin 10 mg in patients with the metabolic syndrome.
Academic Article Effects of one year of treatment with pravastatin, an HMG-CoA reductase inhibitor, on lipoprotein a.
Academic Article Efficacy and safety of eicosapentaenoic acid ethyl ester (AMR101) therapy in statin-treated patients with persistent high triglycerides (from the ANCHOR study).
Academic Article Effect of a monoclonal antibody to PCSK9 on low-density lipoprotein cholesterol levels in statin-intolerant patients: the GAUSS randomized trial.
Academic Article Low-density lipoprotein cholesterol-lowering effects of AMG 145, a monoclonal antibody to proprotein convertase subtilisin/kexin type 9 serine protease in patients with heterozygous familial hypercholesterolemia: the Reduction of LDL-C with PCSK9 Inhibition in Heterozygous Familial Hypercholesterolemia Disorder (RUTHERFORD) randomized trial.
Academic Article Treatment of familial hypercholesterolemia with drugs in children.
Academic Article Effects of AMG 145 on low-density lipoprotein cholesterol levels: results from 2 randomized, double-blind, placebo-controlled, ascending-dose phase 1 studies in healthy volunteers and hypercholesterolemic subjects on statins.
Academic Article Efficacy and tolerability of fluvastatin XL 80 mg alone, ezetimibe alone, and the combination of fluvastatin XL 80 mg with ezetimibe in patients with a history of muscle-related side effects with other statins.
Academic Article Sleep disturbance and HMG CoA reductase inhibitors.
Academic Article Non-statin Treatments for Managing LDL Cholesterol and Their Outcomes.
Academic Article Efficacy and safety of lovastatin therapy in adolescent girls with heterozygous familial hypercholesterolemia.
Academic Article Comparison of PCSK9 Inhibitor Evolocumab vs Ezetimibe in Statin-Intolerant Patients: Design of the Goal Achievement After Utilizing an Anti-PCSK9 Antibody in Statin-Intolerant Subjects 3 (GAUSS-3) Trial.
Academic Article Effect of ezetimibe on plasma adipokines: a systematic review and meta-analysis.
Academic Article Fluvastatin treatment is not associated with an increased incidence of cancer.
Academic Article Efficacy and safety of gemcabene as add-on to stable statin therapy in hypercholesterolemic patients.
Academic Article A 52-week placebo-controlled trial of evolocumab in hyperlipidemia.
Academic Article Achieving LDL cholesterol, non-HDL cholesterol, and apolipoprotein B target levels in high-risk patients: Measuring Effective Reductions in Cholesterol Using Rosuvastatin therapY (MERCURY) II.
Academic Article Efficacy of rosuvastatin compared with other statins at selected starting doses in hypercholesterolemic patients and in special population groups.
Academic Article Efficacy and safety of once-daily vs twice-daily dosing with fluvastatin, a synthetic reductase inhibitor, in primary hypercholesterolemia.
Academic Article Cerivastatin in primary hyperlipidemia: a multicenter analysis of efficacy and safety.
Academic Article Effects of intensive atorvastatin and rosuvastatin treatment on apolipoprotein B-48 and remnant lipoprotein cholesterol levels.
Academic Article Pharmacodynamics, safety, tolerability, and pharmacokinetics of the 0.8-mg dose of cerivastatin in patients with primary hypercholesterolemia.
Academic Article Aggressive treatment of dyslipidemia: a review of supporting evidence.
Academic Article Efficacy and Tolerability of Evolocumab vs Ezetimibe in Patients With Muscle-Related Statin Intolerance: The GAUSS-3 Randomized Clinical Trial.
Academic Article The lower the better? Reviewing the evidence for more aggressive cholesterol reduction and goal attainment.
Academic Article PCSK9 and diabetes: is there a link?
Academic Article Effects of rosuvastatin versus atorvastatin, simvastatin, and pravastatin on non-high-density lipoprotein cholesterol, apolipoproteins, and lipid ratios in patients with hypercholesterolemia: additional results from the STELLAR trial.
Academic Article Effects of maximal atorvastatin and rosuvastatin treatment on markers of glucose homeostasis and inflammation.
Academic Article Drug therapy in children and adolescents with familial hypercholesterolemia.
Academic Article New evidence supporting aggressive lipid lowering.
Academic Article Comparative effects of rosuvastatin and gemfibrozil on glucose, insulin, and lipid metabolism in insulin-resistant, nondiabetic patients with combined dyslipidemia.
Academic Article PCSK9 Inhibitors and Cardiovascular Events.
Academic Article Renal safety of intensive cholesterol-lowering treatment with rosuvastatin: a retrospective analysis of renal adverse events among 40,600 participants in the rosuvastatin clinical development program.
Academic Article Patients with acute coronary syndromes should received statins.
Academic Article Lipoprotein changes with statins.
Academic Article Efficacy and safety of evolocumab in reducing lipids and cardiovascular events.
Academic Article Long-term efficacy and safety of cerivastatin 0.8 mg in patients with primary hypercholesterolemia.
Academic Article Efficacy and safety of rosuvastatin therapy for children with familial hypercholesterolemia.
Academic Article The power of statins: aggressive lipid lowering.
Academic Article Comparison of rosuvastatin versus atorvastatin in patients with heterozygous familial hypercholesterolemia.
Academic Article Safety and efficacy of a monoclonal antibody to proprotein convertase subtilisin/kexin type 9 serine protease, SAR236553/REGN727, in patients with primary hypercholesterolemia receiving ongoing stable atorvastatin therapy.
Academic Article Efficacy and safety of rosuvastatin 40 mg versus atorvastatin 80 mg in high-risk patients with hypercholesterolemia: results of the POLARIS study.
Academic Article Management of hyperlipidemia: whom and when to treat and new statin options.
Academic Article Cerivastatin in primary hyperlipidemia--a multicenter analysis of efficacy and safety.
Academic Article Effect of simvastatin on Lp(a) concentrations.
Academic Article Persistent Safety and Efficacy of Evolocumab in Patients with Statin Intolerance: a Subset Analysis of the OSLER Open-Label Extension Studies.
Academic Article Lipoprotein-associated phospholipase A2 measurements: mass, activity, but little productivity.
Academic Article Extending therapy options in treating lipid disorders: a clinical review of cerivastatin, a novel HMG-CoA reductase inhibitor.
Academic Article Other therapies for reducing low-density lipoprotein cholesterol: medications in development.
Academic Article Effect of a monoclonal antibody to PCSK9, REGN727/SAR236553, to reduce low-density lipoprotein cholesterol in patients with heterozygous familial hypercholesterolaemia on stable statin dose with or without ezetimibe therapy: a phase 2 randomised controlled trial.
Academic Article Apolipoprotein B synthesis inhibition with mipomersen in heterozygous familial hypercholesterolemia: results of a randomized, double-blind, placebo-controlled trial to assess efficacy and safety as add-on therapy in patients with coronary artery disease.
Academic Article New therapies for reducing low-density lipoprotein cholesterol.
Academic Article A dose-titration and comparative study of rosuvastatin and atorvastatin in patients with homozygous familial hypercholesterolaemia.
Academic Article Additional lipid lowering trials using surrogate measurements of atherosclerosis by carotid intima-media thickness: more clarity or confusion?
Academic Article Usefulness of Gemcabene in Homozygous Familial Hypercholesterolemia (from COBALT-1).

Search Criteria
  • Oxidoreductases